Jacob B. Allred

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 6 papers. Top paper: “Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target”.

Transcriptional analysis of metastatic uveal melanoma survival nominates NRP1 as a therapeutic target

Melanoma Research(2020)10.1097/cmr.0000000000000701

N/A

0.757DataRank · unranked

14 citations

Oliver Surriga, Daniel J. Olson, Jacob B. Allred, Carrie Strand, Yuanyuan Zha +11 more

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

Mayo Clinic Proceedings Innovations Quality & Outcomes(2021)10.1016/j.mayocpiqo.2021.05.003

N/A

0.430DataRank · unranked

5 citations

Minetta C. Liu, Jacob B. Allred, Lori A. Erickson, Kandelaria M. Rumilla, Matthew S. Block +5 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.tps11570

N/A

0DataRank · unranked

6 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +8 more

NCI protocol 10250: A phase II study of temozolomide and olaparib for the treatment of advanced uterine leiomyosarcoma.

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.15_suppl.11506

N/A

0DataRank · unranked

11 citations

Jacob B. Allred, Katherine Gano, Suzanne George, Steven Attia, Melissa Burgess +15 more

A multicenter phase II study of cabozantinib + nivolumab for patients (pts) with advanced angiosarcoma (AS) previously treated with a taxane (Alliance A091902).

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.11503

N/A

0DataRank · unranked

35 citations

Jacob B. Allred, Scott M. Schuetze, Elizabeth J. Davis, Michael J. Wagner, Andrew Poklepovic +10 more

Alliance A092104: A randomized phase 2/3 study of olaparib plus temozolomide versus investigator’s choice for the treatment of patients with advanced uterine leiomyosarcoma after progression on prior chemotherapy.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.tps11584

N/A

0DataRank · unranked

2 citations

Sumithra J. Mandrekar, Jacob B. Allred, Stephanie Berg, Martee L. Hensley, Brian Andrew Van Tine +4 more